Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ORAMED PHARMACEUTICALS INC. (ORMP) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ORAMED PHARMACEUTICALS INC. (ORMP), most recent 12 months reported: revenue $2M, net income $174.87M, free cash flow -$5.21M. Latest balance sheet on file: liquid cash $50.61M. From SEC filings. Others in Pharmaceutical Preparations: Korro Bio, Inc. · NORTHWEST BIOTHERAPEUTICS INC · CYCLERION THERAPEUTICS, INC. · Dianthus Therapeutics, Inc. /DE/ · Seres Therapeutics, Inc. · CANNAPHARMARX, INC. · Ovid Therapeutics Inc. · LIPOCINE INC.

Stock screener

Watchlist